This is a routine filing. Monitor the company's next earnings report for any updates on financial performance or strategic direction.
CGON drugs
CGON drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 27 $66.82entry
- T+1 · 7mo ago −1.90%α −1.42% · $65.55
- T+5 · 7mo ago +1.32%α +0.92% · $67.70
- T+20 · 6mo ago −7.38%α −12.33% · $61.89
- T+60 · 4mo ago +3.73%α −1.05% · $69.31
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CG Oncology filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting. This filing follows the recent appointment of Jim DeTore as CFO, which occurred near the same time as this proxy statement. The filing is routine and contains standard proxy information.
Key Financial Metrics
Key Facts
- CG Oncology filed a definitive proxy statement (DEFA14A) for its shareholder meeting.
- The filing follows the recent appointment of Jim DeTore as CFO, which occurred 11 days prior.
- The filing is a standard proxy statement with no indication of an activist campaign or contested vote.
Financial Impact
No immediate financial impact from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-177424 |
| Document: 0001193125-26-177424-index-headers.html | 0001193125-26-177424 |
| Document: 0001193125-26-177424-index.html | 0001193125-26-177424 |
| Document: 0001193125-26-177424.txt | 0001193125-26-177424 |
Track record
25 reports on CGON
6 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +26.33% at T+20 after the Jun 12, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today 8-K Bullish 7/10 Entry $98.84 Now $84.78 −14.23% settles Dec 15
- Nov 16, 2026today Press Release Bullish 7/10 Entry $95.01 Now $84.78 −10.77% settles Dec 15
- Nov 6, 202610d ago 8-K Bearish 5/10 Entry $75.99 Now $84.78 −11.57% settles Dec 7
- Nov 6, 202610d ago Press Release Neutral 4/10 Entry $75.99 Now $84.78 +11.57% settles Dec 7
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $64.06 Now $84.78 +32.34% settles Dec 2
- Oct 19, 202628d ago 3 Neutral 2/10 Entry $61.93 Now $84.78 +36.90% settles Nov 17
- Oct 15, 20264w ago 144 Neutral 2/10 Entry $59.85 to $74.40 Now $84.78 +41.65% ▲ +24.31% +25.47% vs SPY
- Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $63.13 to $74.74 Now $84.78 +34.29% ▲ +18.39% +21.66% vs SPY
- Aug 6, 202614w ago Press Release Bearish 7/10 Entry $74.85 to $74.33 Now $84.78 −13.27% ▲ +0.69% +1.29% vs SPY
- Aug 6, 202614w ago 424B5 Bearish 6/10 Entry $74.85 to $74.33 Now $84.78 −13.27% ▲ +0.69% +1.29% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers